Biowin - Catalogue des membres

Français	/	English

Database of members

Search here for BioWin’s business members.

Would you like to become a member of BioWin and give your company the benefit of the advantages that the cluster offers? Follow the registration process here.

Click here to download the presentation of BioWin's members in Chinese.

Company	Euroscreen SA
Address	Rue Adrienne Bolland, 47 6041 GOSSELIES BELGIUM
Phone	+32 71 34 85 00
Fax	+32 71 34 85 19
VAT number	BE-453325639
Email	info@euroscreen.com
Website	http://www.euroscreen.com/
Contact	COMBALBERT Jean
Activity sector	Biopharma - Pharma Biotech Products
Expertise sector	Small molecule High-throughput screening Allergy Autoimmune diseases Brain diseases Cancer Cardiovascular CNS Dermatology Diabetes Endocrinology Gastrointestinal Genito/urinary Haematology Inflammation Metabolic diseases Obesity Ophtalmic Osteoporosis Other therapeutic areas Pain Respiratory Development Discovery
Activity	Euroscreen is a privately held preclinical-stage company, focused on the discovery and development of small molecule drugs for unmet medical needs. Initially developing and commercializing G Protein-Coupled Receptors (GPCR) reagents, Euroscreen is now developing a pipeline of proprietary preclinical candidates targeting GPCRs, using its worldwide recognized expertise on this critical class of drug targets. Euroscreen pursues a business model combining: Its internal programs on high value targets (Euroscreen DRUG DISCOVERY); with its fully dedicated Services Business Unit (Euroscreen FAST) providing GPCR customized screening and other services for biotech and pharmaceutical companies.
Products	Euroscreen DRUG DISCOVERY : preclinical candidates targeting GPCRs, as well as several preclinical-stage collaborations with partners. Euroscreen FAST : providing GPCR customized screening and other services for biotech and pharmaceutical companies around the world. Euroscreen has also developed a broad target portfolio for licensing intellectual property rights to pharmaceutical companies for the development of therapeutic drugs including CCR5, Chemerin receptor, GPR43, GPR7/8, ORL1-R, FPRL2, purinergic receptors (P2Y4, P2Y11 and P2Y13) and SHIP2.

Back to list

Next member

In the search engine : "Field of activity", the members are classified according to the type of organisation (companies, universities, research units,..)
In the search engine : "keyword", you may type any word too find out all kind of organisations active in that domain (bioinformatics, pre-clinical, cancer, ...)